Viral myocarditis: Identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart

Circulation Research

Volumn 84, Issue 6, 1999, Pages 704-712

  Yang, Decheng ^a   Yu, Jen ^a   Luo, Zongshu ^a   Carthy, Christopher M ^a   Wilson, Janet E ^a   Liu, Zhewei ^a   McManus, Bruce M ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Coxsackievirus; Differential mRNA display; Myocarditis

Indexed keywords

BETA GLOBIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; MYOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC SUSCEPTIBILITY; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; MOUSE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RNA FINGERPRINTING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIRUS MYOCARDITIS;

EID: 0033515431     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.6.704     Document Type: Article

References (55)

1. Grist NR, Reid D. Epidemiology of viral infections of the heart. In: Banatvala JE, ed. Viral Infections of the Heart. London, UK: Edward Arnold; 1993:23-30.
2. Gupta HL, Khare S, Biswas A, Chattopadhya D, Kumari S. Coxsackie B virus in the etiology of heart diseases in Delhi. J Commun Dis. 1995;27: 222-228.
3. Gauntt CJ, Pallansch MA. Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Res. 1996;41:89-99.
4. McManus BM, Kandolf R. Myocarditis: evolving concepts of cause, consequence, and control. Curr Opin Cardiol. 1991;6:418-427.
5. Hohenadl C, Klingel K, Mertsching J, Hofschneider PH, Kandolf R. Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes. 1991;5:11-20.
6. Kandolf R, Klingel K, Mertsching H, Canu A, Hohenadl C, Zell R, Reimann B, Mertsching J, McManus BM, Foulis AK, Hofschneider PH. Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur Heart J. 1991;12:49-55.
7. McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Guy KL, Gauntt CT, Klingel KE, Beisel KW, Kandolf R. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol. 1993;68:159-169.
8. Ukimura A, Deguchi H, Kitaura Y, Fujioka S, Hirasawa M, Kawamura K, Hirai K. Intracellular viral localization in murine coxsackievirus-B3 myocarditis: ultrastructural study by electron microscopic in situ hybridization. Am J Pathol. 1997;150:2061-2071.
9. Lodge PA, Herzum J, Olszewski J, Huber SA. Coxsackievirus B3 myocarditis: acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol. 1987;128:455-453.
10. Andreoletti L, Hober D, Becquart P, Belaich S, Copin MC, Lambert V, Wattre P. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocarditis damage in persistent cardiac infection. J Med Virol. 1997;52:206-214.
11. McManus BM, Chow LH, Wilson JE, Anderson DR, Kandolf R. Direct damage of myocardium by enterovirus: old and new evidence for a pre-eminent injurious role in murine myocarditis. In: Idiopathic Dilated Cardiomyopathy: Structural and Molecular Mechanisms, Clinical Consequences. Berlin, Germany: Springer-Verlag; 1993;284-293.
12. + cells initiate both myocarditis and pancreatitis in DBA/2 mice. Am J Pathol. 1989;135:899-907.
13. Kaplan MH. Coxsackievirus infection in children under 3 months of age. In: Bendinelli M, Friedman H, eds. Coxsackievirus: A General Update. New York, NY: Plenum Press;1988:241-252.
14. Khatib R, Chason JL, Silberberg BK, Lerner AM. Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis. 1980;141:394-403.
15. Grodums EI, Dempster G. The age factor in experimental coxsackie B-3 infection. Can J Micrabiol. 1959;5:595-604.
16. Lyden D, Olszewski J, Huber S. Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age. Cell Immunol. 1987;105:332-339.
17. Van Houten N, Huber SA. Genetics of coxsackie B3 (CVB3) myocarditis. Ear Heart J. 1991(suppl D);12:108-112.
18. Fung YW, Liew CC. Identification of genes associated with myocardial development. Mol Cell Cardiol. 1996;28:1241-1249.
19. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eukaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem. 1982;257:14806-14810.
20. Clark ME, Lieberman PM, Berk AJ, Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol. 1993;13:1232-1237.
21. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257:967-971.
22. Liang P, Zhu W, Zhang X, Guo Z, O'Connell RP, Averboukh L, Wang F, Pardee AB. Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res. 1994;22:5763-5764.
23. Chow LH, Gauntt CJ, McManus BM. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice: a pathologic characterization of heart tissue damage. Lab Invest. 1991;64:55-64.
24. Hohenadl CK, Klingel J, Mertsching PH, Hofschneider PH, Kandolf, R. Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes. 1991;5:11-20.
25. Sambrook T, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989:89-91.
26. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-termination inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463-5467.
27. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25: 3389-3402.
28. Reynafarje B. Simplified method for the determination of myoglobin. J Lab Clin Med. 1963;61:138-145.
29. Yu J, Carthy CM, Bohunek L, Ellis J, Wilson JE, McManus BM, Yang DC. Age-dependent pathogenicity of coxsackievirus B3 in A/J mice: virus genome, virus titre and cytopathological effects in different organs. Cardiovasc Pathol. In press.
30. Barfod ET, Zheng Y, Kuang W-J, Hart MJ, Evans T, Cerione RA, Ashkenazi A. Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain. J Biol Chem. 1993;268:26059-26062.
31. Taylor GA, Jeffers M, Largaespada DA, Jenkins NA, Copeland NG, Woude GFV. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon γ. J Biol Chem. 1996;271:20399-20405.
32. Taylor GA, Stauber R, Rulong S, Hudson E, Pei V, Pavlakis GN, Resan JH, Vande Woude GF. The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J Biol Chem. 1997;272:10639-10645.
33. Loveland B, Wang CR, Vonekawa H, Hermel E, Lindahl KF. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell. 1990;60:971-980.
34. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RN. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 1993;365:855-859.
35. Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature. 1994;370:226-229.
36. Chakravarti D, LaMorte V, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM. Role of CBP/P300 in nuclear receptor signaling. Nature. 1996;383:100-103.
37. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liatta LA, Sobel ME. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200-204.
38. Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 1992;52:6966-6968.
39. Sager R, Anisowicz A, Naveu M, Liang P, Sotiropoulou G. Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J. 1993;7:964-970.
40. Utans U, Liang P, Wyner LR, Karnovsky MJ, Russell ME. Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display. Proc Natl Acad Sci U S A. 1994; 91:6463-6467.
41. Autiere MV, Feuerstein GZ, Yue TL, Ohstein EH, Douglas SA. Use of differential display to identify differentially expressed mRNAs induced by rat carotid artery balloon angioplasty. Lab Invest. 1995;72:656-661.
42. Muntoni F, Cau M, Ganau A. Deletion of the dystrophin muscle-promotor region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921-925.
43. Arber S, Hunter JJ, Ross J Jr. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1997;88:393-403.
44. Wittenberg BA, Wittenberg JB. Myoglobin mediated oxygen delivery to mitochondria of isolated cardiac myocytes. Proc Natl Acad Sci U S A. 1987;84:7503-7507.
45. Chow LH, Beisel KW, McManus BM. Enteroviral infection of mice with severe combined immunodeficiency: Evidence for direct viral pathogenesis of myocardial injury. Lab Invest. 1992;66:24-31.
46. Paty DW, Li DKB. The UBC MS/MRI study group and the IFNβ multiple sclerosis study group. Neurology. 1993;43:662-667.
47. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extract: requirement for dATP and cytochrome c. Cell. 1996;86:147-157.
48. Kluck RM, Bossy-Wetzet E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
49. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/ Caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997; 91:479-489.
50. Leiden JM. The genetics of dilated cardiomyopathy: emerging clues to the puzzle. N Engl J Med. 1997;337:1080-1081.
51. Fentzke RC, Korcarz CE, Lang RM, Lin H, Leiden JM. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J Clin Invest. 1998;101:2415-2426.
52. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap binding protein complex. J Virol. 1988; 62:4407-4409.
53. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B. D'Sa-Eipper C, Chinnadurai G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell. 1994;79:341-351.
54. Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang DC, Hunt DWC, McManus BM. Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol. 1998;72:7669-7675.
55. O'Connel JB, Mason JW. Diagnosing and treating active myocarditis. West J Med. 1989;150:431-435.